REQUEST A DEMO
Total
USD $0.00
Search more companies

Klinicka Biochemia s.r.o. (Slovakia)

Main Activities: HMO Medical Centers
Full name: Klinicka Biochemia s.r.o. Profile Updated: March 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

KLINICKA BIOCHEMIA is a private medical facility that provides comprehensive laboratory services in the fields of clinical biochemistry, clinical immunology, clinical microbiology and clinical hematology. The company began operations on 1th January 2003 and now has a medical laboratories in Zilina, Poprad, Povazska Bystrica, Martin, Kysucke Nove Mesto, Turzovka, Liptovsky Hradok and Spisska Nova Ves.

Headquarters
V.Spanyola 47A
Zilina; Zilinsky; Postal Code: 01001

Contact Details: Purchase the Klinicka Biochemia s.r.o. report to view the information.

Website: http://www.klinickabiochemia.sk

Basic Information
Total Employees:
Purchase the Klinicka Biochemia s.r.o. report to view the information.
Outstanding Shares:
Purchase the Klinicka Biochemia s.r.o. report to view the information.
Registered Capital:
Purchase the Klinicka Biochemia s.r.o. report to view the information.
Incorporation Date:
July 09, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Subsidiaries
BIOHEMLAB, spol. s r.o.
100%
Company Performance
Financial values in the chart are available after Klinicka Biochemia s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-11.82%
Total operating revenue
-12.13%
Operating profit (EBIT)
-14.15%
EBITDA
-14.04%
Net Profit (Loss) for the Period
17.01%
Total assets
32.25%
Total equity
50.8%
Operating Profit Margin (ROS)
-0.72%
Net Profit Margin
9.68%
Return on Equity (ROE)
-10.38%
Debt to Equity Ratio
-0.08%
Quick Ratio
1.12%
Cash Ratio
1.4%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?